Business Development

f-star is looking for partnerships to support the development of therapeutic product candidates. f-star is open to partner its Modular Antibody Technology with pharma and biotech companies with access to proprietary targets or antibodies/antibody fragments who seek to improve their product candidates with f-star's technology. In this regard, f-star is currently engaging in a limited number of feasibility studies, in which the starting molecule provided by the partner will be engineered to display the desired properties. With this approach f-star intends to broaden the scope of its technology and add value to developers of antibody based therapeutics.

To learn more about partnering opportunities with f-star, please contact us.